AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment strategies.

The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 years after it led to one of the country's worst cases of contaminated drinking water.

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can potentially be repurposed for PD treatment.

Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve their overall well-being.

In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation capable of providing sustained release of 17β-Estradiol (E2), a hormone crucial for managing neurodegenerative conditions like PD.

Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating and walking in a mid-stage study.

New legislation signed into law by Governor Kathy Hochul is positioning New York as a leader in Parkinson’s Disease research. The new bill establ

Marc Cohn has taken took Instagram to reveal his hope amid his Parkinson’s disease diagnosis.

New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other neurodegenerative diseases—offering hope for targeted therapies to slow or prevent these conditions.

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's disease report struggling with sleep issues.

Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic options” for the med after it came up short in the efficacy stakes. | Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic options” for the med after it came up short in the efficacy stakes.

The symptoms of Parkinson’s disease could be reversed through injections of nanoparticles into the brain, which is a much less […] The post Parkinson’s Disease Can Be Reversed Through Injecting Nanoparticles Into The Brain appeared first on Chip Chick.